30The transformation of hepatic stellate cells (HSCs) into myofibroblasts is the defining 31 pathobiology in non-alcoholic steatohepatitis (NASH). Here we show that key NASH 32 factors induce IL-11, which drives an autocrine and ERK-dependent activation loop 33 to initiate and maintain HSC-to-myofibroblast transformation, causing liver fibrosis. 34 IL-11 is upregulated in NASH and Il11ra1-deleted mice are strongly protected from 35 liver fibrosis, inflammation and steatosis in murine NASH. Therapeutic inhibition of 36 IL11RA or IL-11 with novel neutralizing antibodies robustly inhibits NASH pathology 37 in preclinical models and reverses established liver fibrosis by promoting HSC 38 senescence and favourable matrix remodelling. When given early in NASH, IL-11 39 inhibition prevents liver inflammation and steatosis, reverses severe hepatocyte 40 damage and reduces hepatic immune cells and TGFβ1 levels. Our findings show an 41 unappreciated and central role for IL-11 in HSCs and prioritise IL-11 signalling as a 42 new therapeutic target in NASH while revealing an unexpected pro-inflammatory 43 function for IL-11 in stromal immunity. 44 45 65 myofibroblasts with shared features 2,9 . We recently identified Interleukin-11 (IL-11) 66 as a crucial factor for cardiovascular and pulmonary fibroblast-to-myofibroblast 67 transformation 10,11 . To date, there are very limited insights into IL-11 in the liver, 68 where it is reported to have anti-inflammatory activity 12,13 , and it is unknown if HSCs 69 respond to IL-11 at all. Here, we explore the hypothesis that IL-11 plays a role in the 70 transformation of HSCs into myofibroblasts and determine the effects IL-11 signalling 71 in the context of liver inflammation, steatosis and fibrosis in NASH.
73
IL-11 activates HSCs and drives liver fibrosis in NASH
74Genome wide RNA-seq analysis revealed that TGFβ1 strongly upregulates IL-11 75 (14.9-fold, P = 3.40x10 -145 ) in HSCs that was confirmed by qPCR and at the protein 76 level and replicated in experiments using precision cut human liver slices ( Fig. 1a-c, 77 Supplementary Fig. 1a). Independent RNA-seq data 14 also show that IL-11 is the 78 most upregulated gene in HSCs when grown on a stiff substrate to model cirrhotic 79 liver ( Supplementary Fig. 1b). HSCs express very low levels of IL6R and higher 80 levels of the IL-11 receptor subunit alpha (IL11RA) than either cardiac or lung 81 fibroblasts ( Fig. 1d, Supplementary Fig. 1c). We also performed Western blots on 82 patient liver samples and found increased IL-11 levels in NASH (Supplementary 83 Fig. 1d,e). These data show that HSCs are both a source and prominent target of IL-84 11 in the human liver and that IL-11 is elevated in NASH. 85 86 To investigate the effect of IL-11 on HSCs, we stimulated cells with either IL-11, 87 TGFβ1 or PDGF. IL-11 activated HSCs to a similar extent as TGFβ1 or PDGF, 88 transforming quiescent HSCs into ACTA2 +ve myofibroblasts that secrete collagen 89 and matrix modifying enzymes ( Fig. 1e-g, Supplementary Fig. ...